S&P 500

5.304,72

0,70%

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

VOR

Vor Biopharma (VOR)

Vor Biopharma Inc

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:VOR

1 2 3 4 5 6 Next >>

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
09/05/2024	22h05	GlobeNewswire Inc.	Vor Bio Reports First Quarter 2024 Financial Results and Provides Company Update	NASDAQ:VOR	Vor Biopharma Inc
09/05/2024	22h01	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:VOR	Vor Biopharma Inc
07/05/2024	22h15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VOR	Vor Biopharma Inc
07/05/2024	22h15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VOR	Vor Biopharma Inc
06/05/2024	14h00	GlobeNewswire Inc.	Vor Bio to Participate in Upcoming Investor Conferences	NASDAQ:VOR	Vor Biopharma Inc
03/05/2024	22h01	GlobeNewswire Inc.	Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:VOR	Vor Biopharma Inc
02/05/2024	22h01	GlobeNewswire Inc.	Vor Bio Appoints Accomplished Oncology and Cancer Immunotherapy R&D Executive, Fouad Namouni, M.D., to its Board of Directors	NASDAQ:VOR	Vor Biopharma Inc
01/04/2024	14h00	GlobeNewswire Inc.	Vor Bio to Participate in Upcoming Investor Conferences	NASDAQ:VOR	Vor Biopharma Inc
20/03/2024	21h05	GlobeNewswire Inc.	Vor Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update	NASDAQ:VOR	Vor Biopharma Inc
05/03/2024	22h15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VOR	Vor Biopharma Inc
05/03/2024	22h15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VOR	Vor Biopharma Inc
05/03/2024	22h01	GlobeNewswire Inc.	Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:VOR	Vor Biopharma Inc
04/03/2024	14h00	GlobeNewswire Inc.	Vor Bio to Participate in Upcoming Investor Conferences	NASDAQ:VOR	Vor Biopharma Inc
14/02/2024	22h08	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:VOR	Vor Biopharma Inc
08/02/2024	23h06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VOR	Vor Biopharma Inc
08/02/2024	23h05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VOR	Vor Biopharma Inc
07/02/2024	14h00	GlobeNewswire Inc.	Vor Bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference	NASDAQ:VOR	Vor Biopharma Inc
02/02/2024	22h01	GlobeNewswire Inc.	Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:VOR	Vor Biopharma Inc
01/02/2024	01h36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VOR	Vor Biopharma Inc
01/02/2024	01h34	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VOR	Vor Biopharma Inc
17/01/2024	22h01	GlobeNewswire Inc.	Vor Bio Doses First AML Patient with VCAR33 (ALLO) and Provides Corporate Update	NASDAQ:VOR	Vor Biopharma Inc
05/01/2024	23h03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VOR	Vor Biopharma Inc
21/12/2023	22h01	GlobeNewswire Inc.	Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:VOR	Vor Biopharma Inc
01/12/2023	22h01	GlobeNewswire Inc.	Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:VOR	Vor Biopharma Inc
27/11/2023	14h00	GlobeNewswire Inc.	Vor Bio to Participate in the JMP Securities Hematology and Oncology Summit	NASDAQ:VOR	Vor Biopharma Inc
09/11/2023	22h01	GlobeNewswire Inc.	Vor Bio Presents Positive Data Update on Trem-cel at HSCT² Conference	NASDAQ:VOR	Vor Biopharma Inc
08/11/2023	22h14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VOR	Vor Biopharma Inc
08/11/2023	22h12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VOR	Vor Biopharma Inc
07/11/2023	22h05	GlobeNewswire Inc.	Vor Bio Reports Third Quarter 2023 Financial Results and Provides Company Update	NASDAQ:VOR	Vor Biopharma Inc
07/11/2023	22h00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:VOR	Vor Biopharma Inc